Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: Don't give up on the second dose!

Allergy. 2021 Sep;76(9):2916-2920. doi: 10.1111/all.14958. Epub 2021 Jun 9.

Authors

Matthew S Krantz¹, Maria A Bruusgaard-Mouritsen², Grace Koo¹, Elizabeth J Phillips³, Cosby A Stone Jr¹, Lene H Garvey²

Affiliations

¹ Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
² Department of Dermatology and Allergy, Allergy Clinic, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
³ Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

No abstract available

Keywords: SARS-CoV; anaphylaxis; vaccines.

Publication types

Letter

MeSH terms

Anaphylaxis*
COVID-19 Vaccines
COVID-19*
Humans
RNA, Messenger
SARS-CoV-2

Substances

COVID-19 Vaccines
RNA, Messenger

Grants and funding